Skip to main content
SpringerLink
Log in

Acromegaly and Diabetes Mellitus: Special Considerations

  • Chapter
  • First Online:
Pituitary Tumors

  • 467 Accesses

Abstract

A 49-year-old man was found to have acromegaly when he was admitted to the hospital for mania, and endocrine was consulted regarding hyperglycemia. He had poorly controlled insulin-dependent diabetes. However, after his acromegaly was treated, first with surgery and then with a somatostatin analog, he was able to come off insulin with good control of diabetes. The relationship between metabolic function and growth hormone excess is discussed in the context of this case.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Colao A, Baldelli R, Marzullo P, Ferretti E, Ferone D, Gargiulo P, et al. Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy. J Clin Endocrinol Metab. 2000;85:193–9.

    PubMed  CAS  Google Scholar 

  2. Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ, Ibbertson HK. Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol. 1994;41:95–102.

    Article  CAS  Google Scholar 

  3. Dreval AV, Trigolosova IV, Misnikova IV, Kovalyova YA, Tishenina RS, Barsukov IA, et al. Prevalence of diabetes mellitus in patients with acromegaly. Endocr Connect. 2014;3:93–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Arosio M, Reimondo G, Malchiodi E, Berchialla P, Borraccino A, De Marinis L, et al. Predictors of morbidity and mortality in acromegaly: an Italian survey. Eur J Endocrinol. 2012;167:189–98.

    Article  CAS  PubMed  Google Scholar 

  5. Fieffe S, Morange I, Petrossians P, Chanson P, Rohmer V, Cortet C, et al. Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry. Eur J Endocrinol. 2011;164:877–84.

    Article  CAS  PubMed  Google Scholar 

  6. Alexopoulou O, Bex M, Kamenicky P, Mvoula AB, Chanson P, Maiter D. Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients. Pituitary. 2014;17:81–9.

    Article  CAS  PubMed  Google Scholar 

  7. Niculescu D, Purice M, Coculescu M. Insulin-like growth factor-I correlates more closely than growth hormone with insulin resistance and glucose intolerance in patients with acromegaly. Pituitary. 2013;16:168–74.

    Article  CAS  PubMed  Google Scholar 

  8. Suda K, Fukuoka H, Iguchi G, Hirota Y, Nishizawa H, Bando H, et al. The prevalence of acromegaly in hospitalized patients with type 2 diabetes. Endocr J. 2015;62:53–9.

    Article  CAS  PubMed  Google Scholar 

  9. Hansen I, Tsalikian E, Beaufrere B, Gerich J, Haymond M, Rizza R. Insulin resistance in acromegaly: defects in both hepatic and extrahepatic insulin action. Am J Phys. 1986;250:E269–73.

    CAS  Google Scholar 

  10. del Rincon JP, Iida K, Gaylinn BD, McCurdy CE, Leitner JW, Barbour LA, et al. Growth hormone regulation of p85alpha expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance. Diabetes. 2007;56:1638–46.

    Article  CAS  PubMed  Google Scholar 

  11. Higham CE, Rowles S, Russell-Jones D, Umpleby AM, Trainer PJ. Pegvisomant improves insulin sensitivity and reduces overnight free fatty acid concentrations in patients with acromegaly. J Clin Endocrinol Metab. 2009;94:2459–63.

    Article  CAS  PubMed  Google Scholar 

  12. Kasayama S, Otsuki M, Takagi M, Saito H, Sumitani S, Kouhara H, et al. Impaired beta-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients. Clin Endocrinol. 2000;52:549–55.

    Article  CAS  Google Scholar 

  13. Katznelson L, Atkinson JL, Cook DM, Ezzat SZ, Hamrahian AH, Miller KK, et al. American Association of Clinical Endocrinologists Medical guidelines for clinical practice for the diagnosis and treatment of acromegaly—2011 update: executive summary. Endocr Pract. 2011;17:636–46.

    Article  PubMed  Google Scholar 

  14. Lim DJ, Kwon HS, Cho JH, Kim SH, Choi YH, Yoon KH, et al. Acromegaly associated with type 2 diabetes showing normal IGF-1 levels under poorly controlled glycemia. Endocr J. 2007;54:537–41.

    Article  CAS  PubMed  Google Scholar 

  15. Wijayaratne DR, Arambewela MH, Dalugama C, Wijesundera D, Somasundaram N, Katulanda P. Acromegaly presenting with low insulin-like growth factor-1 levels and diabetes: a case report. J Med Case Rep. 2015;9:241.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Melmed S, Casanueva F, Cavagnini F, Chanson P, Frohman LA, Gaillard R, et al. Consensus statement: medical management of acromegaly. Eur J Endocrinol. 2005;153:737–40.

    Article  CAS  PubMed  Google Scholar 

  17. Rosario PW, Calsolari MR. Safety and specificity of the growth hormone suppression test in patients with diabetes. Endocrine. 2015;48:329–33.

    Article  CAS  PubMed  Google Scholar 

  18. Kinoshita Y, Fujii H, Takeshita A, Taguchi M, Miyakawa M, Oyama K, et al. Impaired glucose metabolism in Japanese patients with acromegaly is restored after successful pituitary surgery if pancreatic {beta}-cell function is preserved. Eur J Endocrinol. 2011;164:467–73.

    Article  CAS  PubMed  Google Scholar 

  19. Loh JA, Verbalis JG. Diabetes insipidus as a complication after pituitary surgery. Nat Clin Pract Endocrinol Metab. 2007;3:489–94.

    Article  PubMed  Google Scholar 

  20. Zada G, Sivakumar W, Fishback D, Singer PA, Weiss MH. Significance of postoperative fluid diuresis in patients undergoing transsphenoidal surgery for growth hormone-secreting pituitary adenomas. J Neurosurg. 2010;112:744–9.

    Article  CAS  PubMed  Google Scholar 

  21. Mazziotti G, Floriani I, Bonadonna S, Torri V, Chanson P, Giustina A. Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies. J Clin Endocrinol Metab. 2009;94:1500–8.

    Article  CAS  PubMed  Google Scholar 

  22. Breitschaft A, Hu K, Hermosillo Resendiz K, Darstein C, Golor G. Management of hyperglycemia associated with pasireotide (SOM230): healthy volunteer study. Diabetes Res Clin Pract. 2014;103:458–65.

    Article  CAS  PubMed  Google Scholar 

  23. Henry RR, Ciaraldi TP, Armstrong D, Burke P, Ligueros-Saylan M, Mudaliar S. Hyperglycemia associated with pasireotide: results from a mechanistic study in healthy volunteers. J Clin Endocrinol Metab. 2013;98:3446–53.

    Article  CAS  PubMed  Google Scholar 

  24. Colao A, Bronstein MD, Freda P, Gu F, Shen CC, Gadelha M, et al. Pasireotide versus octreotide in acromegaly: a head-to-head superiority study. J Clin Endocrinol Metab. 2014;99:791–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Gadelha MR, Bronstein MD, Brue T, Coculescu M, Fleseriu M, Guitelman M, et al. Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial. Lancet Diabetes Endocrinol. 2014;2:875–84.

    Article  CAS  PubMed  Google Scholar 

  26. Colao A, De Block C, Gaztambide MS, Kumar S, Seufert J, Casanueva FF. Managing hyperglycemia in patients with Cushing's disease treated with pasireotide: medical expert recommendations. Pituitary. 2014;17:180–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neuroendocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

    Lindsay Fourman & Lisa B. Nachtigall

Authors
  1. Lindsay Fourman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lisa B. Nachtigall
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lisa B. Nachtigall .

Editor information

Editors and Affiliations

  1. Neuroendocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

    Lisa B. Nachtigall

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Fourman, L., Nachtigall, L.B. (2018). Acromegaly and Diabetes Mellitus: Special Considerations. In: Nachtigall, L. (eds) Pituitary Tumors. Springer, Cham. https://doi.org/10.1007/978-3-319-90909-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-90909-7_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-90907-3

  • Online ISBN: 978-3-319-90909-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation